Global Glaucoma Treatment Market - Premium Insight, FPNV Positioning Matrix, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2024 (Q4 2018 Update)

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Stakeholders

2. Research & Forecasting

• 2.1. Research Methodology
  • 2.1.1. Research Instruments
    • 2.1.1.1. Secondary Instrument
    • 2.1.1.2. Primary Instrument
  • 2.1.2. Research Approaches
    • 2.1.2.1. Bottom-up Approach
    • 2.1.2.2. Top-down Approach
  • 2.1.3. Research Reliability & Validity
  • 2.1.4. Research Assumptions
  • 2.1.5. Vendor Inclusion Criteria
• 2.2. Forecasting Methodology
  • 2.2.1. Methodology for Market Estimation & Forecasting
  • 2.2.2. Significance and Importance of the Market Estimation & Forecasting

3. Executive Summary

4. Premium Insight

• 4.1. Market Connectivity
• 4.2. Market Data Feed
• 4.3. Market Vendor Ranking Analysis
• 4.4. Market Dynamics
  • 4.4.1. Drivers
  • 4.4.2. Restraints
  • 4.4.3. Opportunities
  • 4.4.4. Challenges
• 4.5. Porter’s Five Forces Analysis
  • 4.5.1. Threat of New Entrants
  • 4.5.2. Threat of Substitutes
  • 4.5.3. Bargaining Power of Customers
  • 4.5.4. Bargaining Power of Suppliers
  • 4.5.5. Industry Rivalry

5. Global Glaucoma Treatment Market, by Indication

• 5.1. Introduction
• 5.2. Angle Closure Glaucoma
• 5.3. Congenital Glaucoma
• 5.4. Open Angle Glaucoma
• 5.5. Secondary Glaucoma

6. Global Glaucoma Treatment Market, by Sales Channel

• 6.1. Introduction
• 6.2. Hospital Pharmacies
• 6.3. Online Sales
• 6.4. Retail Pharmacies

7. Global Glaucoma Treatment Market, by Type

• 7.1. Introduction
• 7.2. Alpha Agonist
• 7.3. Beta Blockers
• 7.4. Carbonic Anhydrase Inhibitors
• 7.5. Cholinergic
• 7.6. Combined Medications
• 7.7. Prostaglandin Analogs

8. Global Glaucoma Treatment Market, by Geography

• 8.1. Introduction
• 8.2. Americas Glaucoma Treatment Market
  • 8.2.1. Americas Glaucoma Treatment Market, by Country
    • 8.2.1.1. United States
    • 8.2.1.2. Brazil
    • 8.2.1.3. Canada
    • 8.2.1.4. Mexico
    • 8.2.1.5. Argentina
  • 8.2.2. Americas Glaucoma Treatment Market, by Indication
  • 8.2.3. Americas Glaucoma Treatment Market, by Sales Channel
  • 8.2.4. Americas Glaucoma Treatment Market, by Type
• 8.3. Europe, Middle East & Africa Glaucoma Treatment Market
  • 8.3.1. Europe, Middle East & Africa Glaucoma Treatment Market, by Country
    • 8.3.1.1. United Kingdom
    • 8.3.1.2. Germany
    • 8.3.1.3. France
    • 8.3.1.4. Saudi Arabia
    • 8.3.1.5. United Arab Emirates
    • 8.3.1.6. Italy
    • 8.3.1.7. Russia
  • 8.3.2. Europe, Middle East & Africa Glaucoma Treatment Market, by Indication
  • 8.3.3. Europe, Middle East & Africa Glaucoma Treatment Market, by Sales Channel
  • 8.3.4. Europe, Middle East & Africa Glaucoma Treatment Market, by Type
• 8.4. Asia-Pacific Glaucoma Treatment Market
  • 8.4.1. Asia-Pacific Glaucoma Treatment Market, by Country
    • 8.4.1.1. China
    • 8.4.1.2. Japan
    • 8.4.1.3. India
    • 8.4.1.4. Australia
  • 8.4.2. Asia-Pacific Glaucoma Treatment Market, by Indication
  • 8.4.3. Asia-Pacific Glaucoma Treatment Market, by Sales Channel
  • 8.4.4. Asia-Pacific Glaucoma Treatment Market, by Type

9. Competitive Strategic Window

• 9.1. Introduction
  • 9.1.1. Leverage Zone
  • 9.1.2. Vantage Zone
  • 9.1.3. Speculative Zone
  • 9.1.4. Bottleneck Zone

10. FPNV Positioning Matrix

• 10.1. Introduction
• 10.2. Scores
  • 10.2.1. Forefront
  • 10.2.2. Pathfinders
  • 10.2.3. Niche
  • 10.2.4. Vital
• 10.3. Business Strategy
• 10.4. Product Satisfaction

11. Competitive News Feed Analysis

12. Company Usability Profiles

• 12.1. Aerie Pharmaceuticals
• 12.2. Akorn, Inc.
• 12.3. Allergan Plc
• 12.4. Bausch & Lomb Incorporated
• 12.5. Merck & Co, Inc.
• 12.6. Mobius Therapeutics, LLC
• 12.7. Novartis AG
• 12.8. Ocular Therapeutix
• 12.9. Perrigo Co. Plc
• 12.10. Pfizer, Inc.
• 12.11. Teva Pharmaceutical Industries Limited

13. Appendix

• 13.1. Top Reports
• 13.2. Author Details

LIST OF TABLES (37 TABLES)

TABLE 1. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, 2016 - 2024 (USD MILLION)

TABLE 2. GLOBAL GLAUCOMA TREATMENT MARKET RANKING, BY VENDORS, 2017

TABLE 3. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2016 - 2024 (USD MILLION)

TABLE 4. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY ANGLE CLOSURE GLAUCOMA, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 5. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY CONGENITAL GLAUCOMA, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 6. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY OPEN ANGLE GLAUCOMA, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 7. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY SECONDARY GLAUCOMA, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 8. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2016 - 2024 (USD MILLION)

TABLE 9. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 10. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY ONLINE SALES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 11. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 12. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)

TABLE 13. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY ALPHA AGONIST, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 14. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY BETA BLOCKERS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 15. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY CARBONIC ANHYDRASE INHIBITORS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 16. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY CHOLINERGIC, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 17. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY COMBINED MEDICATIONS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 18. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY PROSTAGLANDIN ANALOGS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 19. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)

TABLE 20. AMERICAS GLAUCOMA TREATMENT MARKET SIZE, 2016 - 2024 (USD MILLION)

TABLE 21. AMERICAS GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2016 - 2024 (USD MILLION)

TABLE 22. AMERICAS GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2016 - 2024 (USD MILLION)

TABLE 23. AMERICAS GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)

TABLE 24. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA TREATMENT MARKET SIZE, 2016 - 2024 (USD MILLION)

TABLE 25. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2016 - 2024 (USD MILLION)

TABLE 26. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2016 - 2024 (USD MILLION)

TABLE 27. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)

TABLE 28. ASIA-PACIFIC GLAUCOMA TREATMENT MARKET SIZE, 2016 - 2024 (USD MILLION)

TABLE 29. ASIA-PACIFIC GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2016 - 2024 (USD MILLION)

TABLE 30. ASIA-PACIFIC GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2016 - 2024 (USD MILLION)

TABLE 31. ASIA-PACIFIC GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)

TABLE 32. 360IRESEARCH SCORES FOR FOREFRONT IN GLAUCOMA TREATMENT MARKET

TABLE 33. 360IRESEARCH SCORES FOR PATHFINDERS IN GLAUCOMA TREATMENT MARKET

TABLE 34. 360IRESEARCH SCORES FOR NICHE IN GLAUCOMA TREATMENT MARKET

TABLE 35. 360IRESEARCH SCORES FOR VITAL IN GLAUCOMA TREATMENT MARKET

TABLE 36. 360IRESEARCH FPNV POSITIONING MATRIX BUSINESS STRATEGY FOR GLAUCOMA TREATMENT MARKET

TABLE 37. 360IRESEARCH FPNV POSITIONING MATRIX PRODUCT SATISFACTION FOR GLAUCOMA TREATMENT MARKET

LIST OF FIGURES (33 TABLES)

FIGURE 1. GLOBAL GLAUCOMA TREATMENT MARKET: YEARS CONSIDERED FOR THE STUDY

FIGURE 2. GLOBAL GLAUCOMA TREATMENT MARKET: KEY RESEARCH METHODOLOGY

FIGURE 3. GLOBAL GLAUCOMA TREATMENT MARKET: KEY RESEARCH INSTRUMENTS

FIGURE 4. GLOBAL GLAUCOMA TREATMENT MARKET: KEY SECONDARY INSTRUMENT SOURCES

FIGURE 5. GLOBAL GLAUCOMA TREATMENT MARKET: KEY POTENTIAL RESPONDENTS

FIGURE 6. GLOBAL GLAUCOMA TREATMENT MARKET: KEY BREAKDOWN OF PRIMARY INSTRUMENT

FIGURE 7. GLOBAL GLAUCOMA TREATMENT MARKET: KEY RESEARCH APPROACHES

FIGURE 8. GLOBAL GLAUCOMA TREATMENT MARKET: KEY DATA TRIANGULATION

FIGURE 9. GLOBAL GLAUCOMA TREATMENT MARKET: KEY RESEARCH ASSUMPTIONS

FIGURE 10. GLAUCOMA TREATMENT MARKET: KEY MARKET CONNECTIVITY

FIGURE 11. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, 2016 - 2024 (USD MILLION)

FIGURE 12. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY INDICATION, 2017 VS 2024 (USD MILLION)

FIGURE 13. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY ANGLE CLOSURE GLAUCOMA, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 14. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY CONGENITAL GLAUCOMA, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 15. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY OPEN ANGLE GLAUCOMA, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 16. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY SECONDARY GLAUCOMA, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 17. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY SALES CHANNEL, 2017 VS 2024 (USD MILLION)

FIGURE 18. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 19. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY ONLINE SALES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 20. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 21. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY TYPE, 2017 VS 2024 (USD MILLION)

FIGURE 22. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY ALPHA AGONIST, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 23. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY BETA BLOCKERS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 24. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY CARBONIC ANHYDRASE INHIBITORS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 25. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY CHOLINERGIC, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 26. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY COMBINED MEDICATIONS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 27. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY PROSTAGLANDIN ANALOGS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)

FIGURE 28. GLOBAL GLAUCOMA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017 (USD MILLION)

FIGURE 29. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GLAUCOMA TREATMENT MARKET, BY INDICATION, 2024

FIGURE 30. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GLAUCOMA TREATMENT MARKET, BY SALES CHANNEL, 2024

FIGURE 31. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GLAUCOMA TREATMENT MARKET, BY TYPE, 2024

FIGURE 32. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL GLAUCOMA TREATMENT MARKET, BY GEOGRAPHY, 2024

FIGURE 33. 360IRESEARCH FPNV POSITIONING MATRIX FOR GLAUCOMA TREATMENT MARKET